greeksoup/ stock research

Dolby Laboratories (DLB) FY2015 results: revenue $971 million, up 1.1% on the year

Dolby Laboratories, Inc. (DLB) reported revenue of $971 million for fiscal 2015, the year ended 25 September 2015, up 1.1% on the year before. Net income was $181 million, down 12.0%, and diluted earnings per share $1.75. The figures are the company's own, from the 10-K it filed with the SEC on 24 November 2015.

Revenue
$971 million
+1.1% on the year
FY2008FY2015
Operating margin
22.0%
28.5% a year earlier
FY2008FY2015
Net income
$181 million
-12.0% on the year
FY2008FY2015
Diluted EPS
$1.75
-12.1% on the year
FY2008FY2015

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2015FY2014FY2013On the yearLast 8 years
Revenue971960910+1.1%
Cost of revenue94.870.296.7+35.1%
Gross profit876890813-1.6%
Gross margin90.2%92.7%89.4%
Research and development201183169+9.9%
Operating income213274245-22.1%
Operating margin22.0%28.5%27.0%
Interest expense0.2-0.20.6
Pre-tax income246276251-11.0%
Income tax62.567.460.3-7.2%
Effective tax rate25.4%24.4%24.1%
Net income181206189-12.0%
Net margin18.7%21.5%20.8%
Diluted EPS$1.75$1.99$1.84-12.1%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2015FY2014FY2013On the yearLast 8 years
Operating cash flow309362277-14.4%
Capital expenditure15875.426.7+109.1%
Free cash flow152286250-46.9%
Free cash flow margin15.6%29.8%27.5%
Cash from investing-204-205175
Cash from financing-139-40.6-488
Depreciation and amortisation69.153.353.2+29.8%
Share-based compensation67.165.764.3+2.1%
Buybacks10756.082.2+91.6%
Dividends paid41.00.0408
Dividend per share$0.42$0.00$4.00
Diluted shares, weighted104m104m103m+0.2%

Balance sheet

$ millionFY2015FY2014FY2013On the yearLast 8 years
Shareholders' equity1,8071,7101,481+5.7%
Non-controlling interest8.921.618.9-58.7%
Debt0.00.00.0
Other liabilities317252238+25.7%
Total liabilities and equity2,1331,9841,738+7.5%
Fixed assets403290243+39.1%
Goodwill308278280+10.9%
Intangible assets12863.741.3+100.2%
Investments460528447-12.8%
Cash and equivalents532568454-6.4%
Receivables10286.297.5+17.9%
Inventory13.98.510.1+62.5%
Other assets188162165+15.7%
Total assets2,1331,9841,738+7.5%

10-K for the year ended 25 September 2015, filed 24 November 2015: the filing.